The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
about
Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancerCurrent clinical application of serum biomarkers to detect ovarian cancerDesign Characteristics Influence Performance of Clinical Prediction Rules in Validation: A Meta-Epidemiological StudyUltrasonography of ovarian masses using a pattern recognition approach.Reliability of preoperative evaluation of postmenopausal ovarian tumorsKey findings from the International Ovarian Tumor Analysis (IOTA) study: an approach to the optimal ultrasound based characterisation of adnexal pathologyA randomised controlled trial comparing surgical intervention rates between two protocols for the management of asymptomatic adnexal tumours in postmenopausal womenSimple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA groupPolytomous diagnosis of ovarian tumors as benign, borderline, primary invasive or metastatic: development and validation of standard and kernel-based risk prediction models.Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses.Comparison of three malignancy risk indices and CA-125 in the preoperative evaluation of patients with pelvic masses.Natural history of ovarian cancer.Clinically oriented three-step strategy for assessment of adnexal pathology.Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.If the Mountain Does Not Come to Mohammad: The Significance of Guest Operations for Early Stage Ovarian CancerPresurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.Current state of biomarker development for clinical application in epithelial ovarian cancer.Is Risk Malignancy Index a Useful Tool for Predicting Malignant Ovarian Masses in Developing Countries?Multianalyte assay systems in the differential diagnosis of ovarian cancer.Adnexal masses suspected to be benign treated with laparoscopyManagement of a suspicious adnexal mass: a clinical practice guideline.Validity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian CancerEvaluation of selected ultrasonographic parameters and marker levels in the preoperative differentiation of borderline ovarian tumors and ovarian cancersAssessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic massSymptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.Risk of malignancy index as an evaluation of preoperative pelvic mass.Doppler imaging in the diagnosis of ovarian disease.The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging.Adnexal masses: what is the role of ultrasonographic imaging?DNA methylation markers for early detection of women's cancer: promise and challenges.Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspectiveA case for the use of receiver operating characteristic analysis of potential clinical efficacy biomarkers in advanced renal cell carcinoma.Comparison of two protocols for the management of asymptomatic postmenopausal women with adnexal tumours - a randomised controlled trial of RMI/RCOG vs Simple Rules.A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.Ultrasound and doppler in gynecological cancers.First International Consensus Report on Adnexal Masses: Management Recommendations.External validation of the paediatric risk of malignancy index.Performance of the Risk of Malignancy Index for Discriminating Malignant Tumors in Women With Adnexal Masses.
P2860
Q24187351-0B7273E7-74E6-479E-B899-E34F5BF92FE2Q26768709-244FC774-46D4-4043-A9AF-AAFBA2DE2A92Q26770973-1D71A048-BBEB-4676-91EA-713012B73254Q28081941-4C53BBEB-ACF6-43E4-A811-8C4C07638E0EQ30361167-03896569-584A-4D3E-92E3-E698A4930272Q30363494-0EDA35A1-7063-49EC-8549-D7AC58834A52Q30459345-68D94F16-3870-459C-A573-72AA7ACD0280Q30478027-5BD33CAC-5D02-4C46-AC58-4FA5A5B5B33EQ30478283-8B20C98D-F96F-4A62-B2B6-3455AE010929Q30860218-8968A376-10B8-4B33-999F-769CCFFF44CEQ30885682-D831F302-A4CC-4716-812B-5BEF276C7D91Q33937360-2D11056B-D60C-4A66-8221-2C56857E8756Q34249959-84F4CCA5-8D22-4F3E-8DCB-0405EB04E88DQ34268882-4A8A54DD-0BD3-4EE7-9392-4D6F2DF36B35Q34306120-6D87A717-D21E-4AD8-849E-A0CF5476C0D8Q34360602-76610336-A33D-42E7-BAA7-E69EA43458B6Q34391119-3A8914C3-C2FC-465B-A006-18D7226BD19FQ35100951-A3EB6227-AA05-4C4B-B4CC-32C3337B339AQ35817413-94552679-E1C3-4A1A-805F-3DBFD6BBE34EQ35854476-A60CFEDD-4F1E-4A5E-9E4E-A044BA79068BQ36124571-CD6C3F1E-7CC7-479E-935E-8F28FE8968F4Q36136882-A45FA115-74D9-4BDB-A53D-0DB8AABAC1B2Q36370010-1E71F4F2-D7F2-433E-B441-0665F6DF8A03Q36374452-EA018F08-B49B-4977-B7A3-0DE07E95FB63Q36904090-9EFBF6E7-8527-4992-8803-D18C0C4A6B91Q37359954-29365FCA-C6FC-4831-AC94-7C7A4EA5EC60Q37493854-7AE28EA3-EAB4-46A7-8530-8691B6828E82Q38088380-05121FF4-779C-4CD8-A453-DD59B9A8BA32Q38164208-64C01190-D801-4BE3-8BE4-DAA2447EE7C4Q38226600-F7511E31-3BE1-4D83-8E84-4F6A75FB946FQ38238828-4A6E365A-C957-4191-9E2B-65A9F55101C5Q38409656-E9FA0B60-5188-4200-B9BF-B0E29416F24CQ38649539-9DDC9D4D-231F-44AD-8AE0-19079FD0693DQ38931277-598D6CA6-580D-474E-AB50-112D70ADF3DAQ38983866-A58AB7AE-8FFB-4297-A2A1-276D26A4D405Q41395692-D260035F-1328-4231-A980-80940690F23DQ46236279-C82CD02C-1FB0-43B4-BF7E-8311394402CAQ47948339-1908EE1D-F033-4093-91DF-0FCF40457242Q50595771-EABAF343-4909-420D-8489-CF32B0E721FAQ50757337-6378C1DF-3E82-4967-BCEC-4A5BE32420F4
P2860
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@ast
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@en
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@nl
type
label
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@ast
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@en
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@nl
prefLabel
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@ast
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@en
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@nl
P2093
P1476
The accuracy of risk scores in predicting ovarian malignancy: a systematic review.
@en
P2093
Ben W J Mol
Gérard L Bremer
Jeltsje Cnossen
Peggy Geomini
Roy Kruitwagen
P304
P356
10.1097/AOG.0B013E318195AD17
P407
P433
P577
2009-02-01T00:00:00Z